Bioactivation of Tamoxifen by Recombinant Human Cytochrome P450 Enzymes
- 17 April 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 15 (5) , 614-622
- https://doi.org/10.1021/tx0100439
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Roles of NADPH-P450 Reductase in the O-Deethylation of 7-Ethoxycoumarin by Recombinant Human Cytochrome P450 1B1 Variants in Escherichia coliProtein Expression and Purification, 2000
- Synthesis and Reactivity of a Potential Carcinogenic Metabolite of Tamoxifen: 3,4-Dihydroxytamoxifen-o-quinoneChemical Research in Toxicology, 1999
- Reconstitution of Recombinant Cytochrome P450 2C10(2C9) and Comparison with Cytochrome P450 3A4 and Other Forms: Effects of Cytochrome P450–P450 and Cytochrome P450–b5InteractionsArchives of Biochemistry and Biophysics, 1997
- Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomesBiochemical Pharmacology, 1996
- Cytochrome P-450 Mediated Activation and Irreversible Binding of Tamoxifen to Rat and Human Liver ProteinsPublished by Springer Nature ,1992